Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Translational Metabolism
Published in: Clinical Reviews in Bone and Mineral Metabolism 4/2017

Open Access 01-12-2017 | Review Paper

A Review on Bone Mineral Density Loss in Total Knee Replacements Leading to Increased Fracture Risk

Authors: M. Gundry, S. Hopkins, K. Knapp

Published in: Clinical & Translational Metabolism | Issue 4/2017

Login to get access

Abstract

The link between low bone mineral density (BMD) scores leading to greater fracture risk is well established in the literature; what is not fully understood is the impact of total knee replacements/revisions or arthroplasties on BMD levels. This literature review attempts to answer this question. Several different databases using specific key terms were searched, with additional papers retrieved via bibliographic review. Based on the available evidence, total knee replacements/revisions and arthroplasties lower BMD and thus increase fracture risk. This review also addresses the possible implications of this research and possible options to reduce this risk.
Literature
1.
Lohmander SL. Knee replacement for osteoarthritis; facts, hopes, and fears. Medicographia. 2013;35(2):181–8.
2.
Koskinen EA, et al. Comparison of survival and cost-effectiveness between unicondylar arthroplasty and total knee arthroplasty in patients with primary osteoarthritis: a follow-up study of 50, 493 knee replacements from the Finnish Arthroplasty Register. Acta Orthop. 2008;79(4):499–507.PubMed
3.
Knutson K, Lewold S, et al. The Swedish knee arthroplasty register. A nation-wide study of 30,003 knees 1976–1992. Acta Orthop Scand. 1994;65(4):375–86.PubMed
4.
Hawker G, Wright J, et al. Health-related quality of life after knee replacement. J Bone Joint Surg Am. 1998;80(2):163–73.PubMed
5.
6.
Foss MVL, Byers PD. Bone density, osteoarthritis of the hip, and fracture of the upper end of the femur. Ann Rheum Dis. 1972;31:259–64.PubMedPubMedCentral
7.
Arokoski JPA, Arokoski MH, et al. Estimation of femoral head bone density using magnetic resonance imaging: comparison between men with and without hip osteoarthritis. J Clin Densitom. 2004;7(2):183–91.PubMed
8.
Chaganti RK, Parimi N, et al. Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group. Osteoporos Int. 2010;21(8):1307–16.PubMedPubMedCentral
9.
Dequeker J, Aerssens J, et al. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res. 2003;15(5):426–39.PubMed
10.
Hart CC, et al. The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford study. Arthritis Rheum. 2002;46(1):92–9.PubMed
11.
Lethbridge-Cejku M, Tobin JD, et al. Axial and hip bone mineral density and radiographic changes of osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. J Rheumatol. 1996;23(11):1943–7.PubMed
12.
Nevitt MC, Lane NE, et al. Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. Arthritis Rheum. 1995;38(7):907–16.PubMed
13.
Hochberg MC, Lethbridge-Cejku M, et al. Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. Osteoarthr Cartil. 2004;12:45–8.
14.
El Miedany YM, Mehanna AN, et al. Altered bone mineral metabolism in patients with osteoarthritis. Joint Bone Spine. 2000;67(6):521–7.PubMed
15.
Perry ME, et al. Relationships between self-reported osteoarthritis (OA), bone mineral density (BMD) and radiographic scores using dual energy X-ray absorptiometry (DXA). Scott Med J. 2015;60(3):25–33.
16.
Hannan MT, Andersin JJ, et al. Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum. 1993;36(12):1671–80.PubMed
17.
Demirağ MD, Özkan S, et al. Associations between obesity and the radiographic phenotype in knee osteoarthritis. Turk J Med Sci. 2017;47(2):424–9.PubMed
18.
Crowninshield RD, Rosenberg AG, et al. Changing demographics of patients with total joint replacement. Clin Orthop Relat Res. 2006;443:266–72.PubMed
19.
Arden NK, Griffiths GO, et al. The association between osteoarthritis and osteoporotic fracture: the Chingford Study. Br J Rheumatol. 1996;35:1299–304.PubMed
20.
Arden NK, Crozier S, et al. Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum. 2006;55(4):610–5.PubMed
21.
Bergink AP, Van Der Klift M, et al. Osteoarthritis of the knee is associated with vertebral and nonvertebral fractures in the elderly: the Rotterdam Study. Arthritis Care Res. 2003;49:648–57.
22.
Chan MY, Center JR, et al. Bone mineral density and association of osteoarthritis with fracture risk. Osteoarthr Cartil. 2014;22(9):1251–8.PubMed
23.
Jones G, Nguyen T, et al. Osteoarthritis, bone density, postural stability, and osteoporotic fractures: a population based study. J Rheumatol. 1995;22(5):921–5.PubMed
24.
Lee S, Kim TN, et al. Knee osteoarthritis is associated with increased prevalence of vertebral fractures despite high systemic bone mineral density: a cross-sectional study in an Asian population. Mod Rheumatol. 2014;24(1):174–81.
25.
Birch C, Hunter D, et al. Development of a novel imaging process to determine the clinical applicability of bone mineral density assessment of the osteoarthritic knee: a research proposal. Work Pap Health Sci. 2014;1(9):1–7.
26.
Liu G, Peacock M, et al. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int. 1997;7(6):564–9.PubMed
27.
Ding M, Odgaard A, et al. Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg Br Vol. 2003;85(6):906–12.
28.
Mansell JP, Bailey AJ. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Investig. 1998;101(8):1596–603.PubMedPubMedCentral
29.
Legrand E, Chappard D, et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res. 2000;15(1):13–9.PubMed
30.
Manninen P, Riihimäki H, et al. Overweigh gender and knee osteoarthritis. Int J Obes. 1996;20(6):595–7.
31.
Yang S, Shen X. Association and relative importance of multiple obesity measures with bone mineral density: the national health and nutrition examination survey 2005–2006. Arch Osteoporos. 2015;10:14.PubMed
32.
Papakitsou EF, Margioris AN, et al. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas. 2004;47(3):185–93.PubMed
33.
34.
Saito M, Kida Y, et al. Diabetes, collagen and bone quality. Curr Osteoporos Rep. 2014;12(2):181–8.PubMed
35.
McNerny EMB, Nikolas TL. Bone quality in chronic kidney disease: definitions and diagnostics. Curr Osteoporos Rep. 2017;15(3):207–13.PubMed
36.
Vestergaard P, Rejnmark L, et al. Osteoarthritis and risk of fractures. Calcif Tissue Int. 2009;84(4):249–56.PubMed
37.
Cumming RG, Klineberg RJ. Epidemiological study of the relation between arthritis of the hip and hip fractures. Ann Rheum Dis. 1993;52:707–10.PubMedPubMedCentral
38.
Arden NK, Nevitt MC, et al. Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Arthritis Rheum. 1999;42(7):1378–85.PubMed
39.
Jones G, Nquyen T, et al. A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol. 1995;22(5):932–6.PubMed
40.
Vennu V, Bindawas SM. Relationship between falls, knee osteoarthritis, and health-related quality of life: data from the Osteoarthritis Initiative study. J Clin Interv Aging. 2014;9:793–800.
41.
Doré AL, Golightly YM, et al. Lower-extremity osteoarthritis and the risk of falls in a community-based longitudinal study of adults with and without osteoarthritis. Arthritis Care Res. 2015;67(5):633–9.
42.
Lalmohamed A, Opdam F, et al. Knee arthroplasty and risk of hip fracture: a population-based, case–control study. Calcif Tissue Int. 2012;90(2):144–50.PubMed
43.
Prieto-Alhambra D, Javaid MK, et al. Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis. 2011;70(1):134–8.PubMed
44.
Bousson V, Bergot C, et al. Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects. Osteoporos Int. 2012;23(5):1489–501.PubMed
45.
Hopkins SJ, Toms AD, et al. A study investigating short- and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk. Osteoporos Int. 2016;27(8):2567–76.PubMed
46.
Hopkins SJ, Smith CW, et al. Relationship between spine bone mineral density and trabecular bone score in postmenopausal populations following total knee replacement or leg fracture. Osteoporos Int. 2012;23:S582.
47.
Legrand E, Chappard D, et al. Bone mineral density and vertebral fractures in men. Osteoporos Int. 1999;10:265–70.PubMed
48.
Marshall D, Johnell O, et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J. 1996;312(7041):1254–9.
49.
De Laet CE, Van Hout BA, et al. Bone density and risk of hip fracture in men and women: cross sectional analysis. Br Med J. 1997;315(7102):221–5.
50.
Cummings SR, Black DM, et al. Bone density at various sites for prediction of hip fractures. Lancet. 1993;341(8837):72–5.PubMed
51.
Cummings SR, Nevitt MC, et al. Risk factor for hip fracture in white women. N Engl J Med. 1995;332(12):767–74.PubMed
52.
Melton LJ 3rd, Wahner HW, et al. Osteoporosis and the risk of hip fracture. Am J Epidemiol. 1986;124(2):254–61.PubMed
53.
Beaupre LA, Rezansoff A, et al. Bone mineral density changes in the hip and spine of men and women 1-year after primary cemented total knee arthroplasty: prospective cohort study. J Arthroplast. 2015;30(15):2185–9.
54.
Gazdzik TS, Gajda T, et al. Bone mineral density changes after total knee arthroplasty: one-year follow-up. J Clin Densitom. 2008;11(3):345–50.PubMed
55.
Ishii Y, Yagisawa K, et al. Changes in bone mineral density of the proximal femur after total knee arthroplasty. J Arthroplast. 2000;15(4):519–22.
56.
Kim KK, Won YY, et al. Changes in bone mineral density of both proximal femurs after total knee arthroplasty. Clin Orthop Surg. 2014;6(1):43–8.PubMedPubMedCentral
57.
Li MG, Nilsson KG. Changes in bone mineral density at the proximal tibia after total knee arthroplasty: a 2-year follow-up of 28 knees using dual energy X-ray absorptiometry. J Orthop Res. 2000;18(1):40–7.PubMed
58.
Liu TK, Yang RS, et al. Periprosthetic bone mineral density of the distal femur after total knee arthroplasty. Int Orthop. 1995;19(6):346–51.PubMed
59.
Petersen MM, Nielsen PT, et al. Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A 3-year follow-up of 25 knees. Acta Orthop Scand. 1995;66(6):513–6.PubMed
60.
Soininvaara TA, Miettinen HJ, et al. Bone mineral density in the proximal femur and contralateral knee after total knee arthroplasty. J Clin Densitom. 2004;7(4):424–31.PubMed
61.
Soininvaara TA, Miettinen HJ, et al. Periprosthetic tibial bone mineral density changes after total knee arthroplasty: one-year follow-up study of 69 patients. Acta Orthop Scand. 2004;75(5):600–5.PubMed
62.
Mau-Moeller A, Behrens M, et al. Modulation and predictors of periprosthetic bone mineral density following total knee arthroplasty. Biomed Res Int. 2015;2015:418168.PubMedPubMedCentral
63.
Järvenpää J, Soininvaara TA, et al. Changes in bone mineral density of the distal femur after total knee arthroplasty: a 7-year DEXA follow-up comparing results between obese and nonobese patients. Knee J. 2014;21(1):232–5.
64.
Mintzer CM, Robertson DD, et al. Bone loss in the distal anterior femur after total knee arthroplasty. Clin Orthop Relat Res. 1990;260:135–43.
65.
Jaroma A, Soininvaara TA, et al. Periprosthetic tibial bone mineral density changes after total knee arthroplasty a 7-year follow-up of 86 patients. Acta Orthop. 2016;87(3):268–73.PubMedPubMedCentral
66.
Lavernia CJ, Rodriguez JA, et al. Bone mineral density of the femur in autopsy retrieved total knee arthroplasties. J Arthroplast. 2014;29(8):1681–6.
67.
Lonner JH, Klotz M, et al. Changes in bone density after cemented total knee arthroplasty: influence of stem design. J Arthroplast. 2001;16(1):107–11.
68.
Im GI, Kwon OJ, et al. The relationship between osteoarthritis of the knee and bone mineral density of proximal femur: a cross-sectional study from a Korean population in women. Clin Orthop Surg. 2014;6(4):420–5.PubMedPubMedCentral
69.
Karbowski A, Schwitalle M, et al. Periprosthetic bone remodelling after total knee arthroplasty: early assessment by dual energy X-ray absorptiometry. Arch Orthop Trauma Surg. 1999;119(5–6):324–6.PubMed
70.
Levitz CL, Lotke PA, et al. Long-term changes in bone mineral density following total knee replacement. Clin Orthop Relat Res. 1995;321:68–72.
71.
Van Loon CJ, Oyen WJ, et al. Distal femoral bone mineral density after total knee arthroplasty: a comparison with general bone mineral density. Arch Orthop Trauma Surg. 2001;121(5):282–5.PubMed
72.
Hahn MH, Won YY. Bone mineral density changes after total knee replacement in women over the age of 65. J Bone Metab. 2013;20(2):105–9.PubMedPubMedCentral
73.
Petersen MM, Gehrchen PM, et al. Effect of hydroxyapatite-coated tibial components on changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty: a prospective randomized study using dual-energy x-ray absorptiometry. J Arthroplast. 2005;20(4):516–20.
74.
Mann T, Eisler T, et al. Larger femoral periprosthetic bone mineral density decrease following total hip arthroplasty for femoral neck fracture than for osteoarthritis: a prospective, observational cohort study. J Orthop Res. 2015;33(4):504–12.PubMed
75.
Cameron HU, Cameron G. Stress-relief osteoporosis of the anterior femoral condyles in total knee replacement: a study of 185 patients. Orthop Rev. 1987;16(7):449–56.PubMed
76.
Van Lenthe GH, de Waal Malefijt MC, et al. Stress shielding after total knee replacement may cause bone resorption in the distal femur. J Bone Joint Surg Br Vol. 1997;79(1):117–22.
77.
Hopkins SJ, Smith CW, et al. A study investigating the long-term effects on function, bone mineral density and lean tissue mass post total knee replacement in a female postmenopausal population. Osteoporos Int. 2012;23:S552.
78.
Meek RM, Norwood T, et al. The risk of peri-prosthetic fracture after primary and revision total hip and knee replacement. Bone Joint J. 2011;93(1):96–101.
79.
Toogood PA, Vail TP. Periprosthetic fractures: a common problem with a disproportionately high impact on healthcare resources. J Arthroplast. 2015;30(10):1688–91.
80.
81.
Cordeiro EN, Costa RC, et al. Periprosthetic fractures in patients with total knee arthroplasties. Clin Orthop Relat Res. 1990;252:182–9.
82.
Dennis DA. Periprosthetic fractures following total knee arthroplasty. J Bone Joint Surg (Am Vol). 2001;83(1):120–30.
83.
Merkel KD, Johnson EW Jr. Supracondylar fracture of the femur after total knee arthroplasty. J Bone Joint Surg (Am Vol). 1986;68(1):29–43.
84.
Engh GA, Ammeen DJ, et al. Instructional course lectures, the american academy of orthopaedic surgeons—periprosthetic fractures adjacent to total knee implants. Treatment and clinical results. J Bone Joint Surg (Am Vol). 1997;79:1100–13.
85.
Beals RK, Tower SS. Periprosthetic fractures of the femur. An analysis of 93 fractures. Clin Orthop Relat Res. 1996;327:238–46.
86.
Matsumoto H, Okuno M, et al. Incidence and risk factors for falling in patients after total knee arthroplasty compared to healthy elderly individuals. Yonago Acta Medica. 2014;57(4):137–45.PubMedPubMedCentral
87.
Soison A, Riratanapong S, et al. Prevalence of fall in patients with total knee arthroplasty living in the community. J Med Assoc Thail. 2014;97(12):1338–43.
88.
Ikutomo H, Nagai K, et al. Falls in patients after total hip arthroplasty in Japan. J Orthop Sci. 2015;20(4):663–8.PubMed
89.
Swinkels A, Allain TJ. Physical performance tests, self-reported outcomes, and accidental falls before and after total knee arthroplasty: an exploratory study. Physiother Theory Pract. 2013;29(6):432–42.PubMed
90.
Swinkels A, Newman JH, et al. A prospective observational study of falling before and after knee replacement surgery. Age Ageing. 2009;38(2):175–81.PubMed
91.
Carulli C, Civinini R, et al. The use of anti-osteoporosis drugs in total knee arthroplasty. Aging Clin Exp Res. 2011;23(2):38–9.PubMed
92.
Prieto-Alhambra D, Javaid MK, et al. Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Osteoporos Int. 2011;22(5):1555–71.PubMed
93.
Teng S, Yi C, et al. Bisphosphonate use and risk of implant revision after total hip/knee arthroplasty: a meta-analysis of observational studies. Public Libr Sci. 2015;10(10):e0139927.
94.
Ma S, Goh EL. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Sci Rep. 2017;7:43399.PubMedPubMedCentral
95.
Kharwadkar N, Mayne B, et al. Bisphosphonates and atypical subtrochanteric fractures of the femur. Bone Joint Res. 2017;6(3):144–53.PubMedPubMedCentral
96.
Bjarnason NH, Hassager C, et al. Postmenopausal bone remodelling and hormone replacement. Clim J Int Menopause Soc. 1998;1(1):72–9.
97.
Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. J Am Med Assoc. 2001;285(22):2891–7.
98.
Lufkin EG, Wahner HW, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117(1):1–9.PubMed
99.
Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet. 2003;362(9382):419–27.PubMed
100.
Jordan N, Barry M, et al. Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women. Clin Interv Aging. 2006;1(4):377–87.PubMedPubMedCentral
101.
Ettinger B, Black DM, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. J Am Med Assoc. 1999;282(7):637–45.
102.
Romero A, Alonso C, et al. Risk of venous thromboembolic disease in women a qualitative systematic review. Eur J Obstet Gynecol Reprod Biol. 2005;121(1):8–17.PubMed
103.
Cosman F, Baz-Hecht M, et al. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb Res. 2005;116(1):1–13.PubMed
104.
Arnett T. Basics of bone biology. Osteoporos Rev. 2015;23(2):12–6.
105.
106.
Borba VZC, Manas NCP. The use of PTH in the treatment of osteoporosis. Arq Bras Endocrinol Metabol. 2010;54(2):213–9.PubMed
107.
Almeida MM, Nani EP, et al. Strontium ranelate increases osteoblast activity. Tissue Cell. 2016;48(3):183–8.PubMed
108.
National Osteoporosis Society. National osteoporosis update. Osteoporos Rev. 2017;25(1):14.
109.
Abrahamsen B, Grove EL, et al. Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int. 2014;25(2):757–62.PubMed
110.
Minoda Y, Ikebuchi M, et al. A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study. J Bone Joint Surg Br Vol. 2010;92(6):794–8.
111.
Zhang QH, Cossey A, et al. Stress shielding in periprosthetic bone following a total knee replacement: effects of implant material, design and alignment. Med Eng Phys. 2016;38(12):1481–8.PubMed
112.
Howard JL, Kudera LE, et al. Early results of the use of tantalum femoral cones for revision total knee arthroplasty. J Bone Joint Surg Am. 2011;93(5):478–84.PubMed
113.
Lachiewicz B, Handerson RA, et al. Can tantalum cones provide fixation in complex revision knee arthroplasty? Clin Orthop Relat Res. 2012;470(1):199–204.PubMed
114.
Harrison AK, Gioe TJ, et al. Do porous tantalum implants help preserve bone?: Evaluation of tibial bone density surrounding tantalum tibial implants in TKA. Clin Orthop Relat Res. 2010;468(10):2739–45.PubMedPubMedCentral
115.
Winther N, Jensen C, et al. Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A prospective randomized study. Int Orthop. 2016;40(2):285–94.PubMed
116.
Minoda Y, Kobayashi A, et al. Porous tantalum tibial component prevents periprosthetic loss of bone mineral density after total knee arthroplasty for five years-a matched cohort study. J Arthroplast. 2013;28(10):1760–4.
117.
Jensen CL, Petersen MM, et al. Bone mineral density changes of the proximal tibia after revision total knee arthroplasty. A randomised study with the use of porous tantalum metaphyseal cones. Int Orthop. 2012;36(9):1857–63.PubMedPubMedCentral
118.
Faizan A, Bhowmik-Stoker M, et al. Development and verification of novel porous titanium metaphyseal cones for revision total knee arthroplasty. J Arthroplast. 2017;32(6):1946–53.
119.
Family R, Solati-Hashjin M, et al. Surface modification for titanium implants by hydroxyapatite nanocomposite. Caspian J Intern Med. 2012;3(3):460–5.PubMedPubMedCentral
120.
Cook SD, Thomas KA, et al. Hydroxyapatite-coated for orthopaedic implant applications. Clin Orthop Relat Res. 1988;232:225–43.
121.
Bøe BG, Støen RØ, et al. Coating of titanium with hydroxyapatite leads to decreased bone formation. Bone Joint Res. 2012;1(6):125–30.PubMedPubMedCentral
122.
Watters TS, Martin JR, et al. Porous-coated metaphyseal sleeves for severe femoral and tibial bone loss in revision TKA. J Arthroplast. 2017;S0883-5403(17):30536–3.
123.
Dalury DF, Barrett WP. The use of metaphyseal sleeves in revision total knee arthroplasty. Knee. 2016;23(3):545–8.PubMed
124.
Maier GS, Kolbow K, et al. The importance of bone mineral density in hip arthroplasty: results of a survey asking orthopaedic surgeons about their opinions and attitudes concerning osteoporosis and hip arthroplasty. Adv Orthop. 2016;2016:8079354.PubMedPubMedCentral
125.
Di Gregorio S, Del Rio L, et al. Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS). Bone J. 2015;75:138–43.
126.
Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929–36.PubMed
127.
Ferket BS, Feldman Z, et al. Impact of total knee replacement practice: cost effectiveness analysis of data from the osteoarthritis initiative. Br Med J. 2017;356:j1131.
128.
Skou ST, Roos EM, et al. A randomized controlled trial of total knee replacement. New J Med. 2015;373:1597–606.
129.
Robertsson O, Dunbar M, et al. Patient satisfaction after knee arthroplasty: a report on 27,372 knees operated on between 1981 and 1995 in Sweden. Acta Orthop Scand. 2000;71(3):262–7.PubMed
Metadata
Title
A Review on Bone Mineral Density Loss in Total Knee Replacements Leading to Increased Fracture Risk
Authors
M. Gundry
S. Hopkins
K. Knapp
Publication date
01-12-2017
Publisher
Springer US
Published in
Clinical & Translational Metabolism / Issue 4/2017
Print ISSN: 1534-8644
Electronic ISSN: 2948-2445
DOI
https://doi.org/10.1007/s12018-017-9238-4
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits